Item 9A. Controls and Procedures
Item 9A. Controls and Procedures
The Company maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in reports filed by the Company under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms and that such information is accumulated and communicated to the Company’s management, including its Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure. The Company’s Chief Executive Officer and Chief Financial Officer evaluated, with the participation of the Company’s management, the effectiveness of the Company’s disclosure controls and procedures (as defined in Exchange Act Rule 13a-15(e)), as of March 31, 2026. Based on this evaluation, the Company’s management, including its Chief Executive Officer and Chief Financial Officer, concluded that the Company’s disclosure controls and procedures were effective as of March 31, 2026.
Management’s Report on Internal Control Over Financial Reporting
The Company’s management is responsible for establishing and maintaining effective internal control over financial reporting as defined in Rule 13a-15(f) under the Exchange Act. The Company’s internal control over financial reporting is designed to provide reasonable assurance to management and the Board of Directors regarding the preparation and fair presentation of the consolidated financial statements. Due to inherent limitations, internal control over financial reporting may not prevent or detect all errors or misstatements in the financial statements, and even control procedures that are determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions.
As required by Exchange Act Rule 13a-15(c), the Company’s Chief Executive Officer and Chief Financial Officer, with the participation of other members of management, assessed the effectiveness of the Company’s internal control over financial reporting as of March 31, 2026. The evaluation was based on the criteria set forth in “Internal Control – Integrated Framework” issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework). Based on this assessment, the Company’s management concluded that the Company’s internal control over financial reporting was effective at the reasonable assurance level as of March 31, 2026.
Remediation of Previously Disclosed Material Weakness
As previously disclosed under Item 9a, “Controls and Procedures” in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2025, the Company’s management previously concluded that the Company’s internal control over financial reporting was not effective as of March 31, 2025 as a result of certain control deficiencies that were determined to constitute a material weakness in its internal control over financial reporting. Specifically, the Company’s management determined that the internal controls at one of the Company’s tobacco subsidiaries were not effectively documented and executed to ensure that the existence of all dark air-cured tobacco inventories subject to physical inventory counts were appropriately counted, and that the controls related to the compilation and reconciliation of the related inventory to ensure complete and accurate reporting of inventory in the consolidated financial statements were not effective. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of a company’s annual or interim financial statements will not be prevented or detected on a timely basis.
While the material weakness did not result in a material misstatement of the Company’s consolidated financial statements for the fiscal year ended March 31, 2025, there was a reasonable possibility that these deficiencies could have resulted in a material misstatement of the Company’s annual or interim consolidated financial statements that would not be prevented or detected on a timely basis.
To remediate the material weakness described above, the Company successfully implemented the following remediation steps at the tobacco subsidiary:
1. Required enhanced documentation associated with management review controls and validation of the completeness and accuracy of key reports used across the inventory process, including physical inventory counts.
2. Designed and implemented additional reports to be utilized in inventory reconciliation controls at the subsidiary.
Based on management’s evaluation of the effectiveness of the Company’s internal controls as of March 31, 2026, management concluded that the previously identified material weakness had been successfully remediated as of March 31, 2026.
92
The Company’s independent registered public accounting firm, Ernst & Young LLP, audited the Company’s internal control over financial reporting as of March 31, 2026. See “Report of Ernst & Young LLP, Independent Registered Public Accounting Firm” in Item 8.
Changes in Internal Control Over Financial Reporting
There were no changes in the Company’s internal control over financial reporting that occurred during the Company’s last fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
Item 9B. Other Information
On March 2, 2026, Johan C. Kroner adopted a Rule 10b5-1 trading arrangement (as such term is defined in Item 408 of Regulation S-K of the Securities Act of 1933) providing for the sale from time to time of an aggregate of up to 33,250 shares of common stock. The duration of the trading arrangement is until all shares of common stock subject to the trading arrangement have been sold. Mr. Kroner was the Company’s Senior Vice President and Chief Financial Officer at the time he entered into the Rule 10b5-1 trading arrangement.
Except as provided above, during the three months ended March 31, 2026, none of our directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) adopted or terminated a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K of the Securities Act of 1933).
Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections
None.
93
PART III
Item 10. Directors, Executive Officers, and Corporate Governance
Except as to the matters set forth below, information required by this Item is incorporated herein by reference to the Company’s definitive Proxy Statement for its 2026 Annual Meeting of Shareholders, which is expected to be held on August 4, 2026 (the “2026 Proxy Statement”).
Information About Our Executive Officers as of June 1, 2026:
Name and Age Position Business Experience During Past The Five Years
P. D. Wigner (57) Chairman, President, and Chief Executive Officer Mr. Wigner was elected Chairman, President, and Chief Executive Officer in October 2024. He served as Senior Vice President since April 2024, Vice President since August 2007, and General Counsel and Secretary since November 2005. He also served as Chief Compliance Officer from November 2007 until September 2012. Mr. Wigner served as Senior Counsel of Universal Leaf from November 2004 until November 2005. He has been employed with the Company since 2003.
S. S. Diel (54) Senior Vice President and Chief Financial Officer Mr. Diel was elected Senior Vice President and Chief Financial Officer in April 2026, having previously served as Vice President, Business Development from May 2018 to April 2026. He has been employed with the Company since May 2018.
A. L. Hentschke (56) Senior Vice President and Chief Operating Officer Mr. Hentschke was elected Senior Vice President and Chief Operating Officer in April 2015. From January 2013 to April 2015, he served as Executive Vice President of Universal Leaf Tobacco Company, Incorporated (“Universal Leaf”). From November 2009 to January 2013, Mr. Hentschke served as President and Chief Executive Officer of Universal Leaf Tabacos, Limitada, the Company's operating subsidiary in Brazil. He has been employed with the Company and its affiliates since 1991.
C. H. Claiborne (65) Vice President, General Counsel and Secretary Mrs. Claiborne was elected as General Counsel and Secretary effective April 2024. She also has served as Vice President since February 2018 having previously served as Vice President and Assistant Secretary from February 2018 to April 2024. From October 2004 to February 2018, Mrs. Claiborne served as Vice President, Associate General Counsel, and Secretary of Universal Leaf. She has been employed with the Company since December 1999.
J. Patrick O’Keefe (57) Vice President, Ingredients Mr. O’Keefe was elected Vice President, Ingredients effective May 2023. Mr. O’Keefe is also Senior Vice President of Universal Global Ventures, Inc., a position he has held since April 2020. Prior to joining the Company in April 2020, Mr. O’Keefe was employed by Allen Flavors since July 2018, having served as their Chief Operating Officer, Americas from December 2018 until March 2020.
S. J. Bleicher (49) Vice President and Controller Mr. Bleicher was elected Vice President and Controller in June 2019. Mr. Bleicher joined the Company in August 2014 and served as Assistant Controller through May 2019.
M. Starke (50) Senior Vice President and Sales Director Mr. Starke was elected Senior Vice President and Sales Director of Universal Leaf effective July 2023. He has served as Senior Vice President since 2017, as Vice President from January 2012 until February 2017, and Assistant Vice President from October 2007 until January 2012. Mr. Starke joined the Company in 1999.
There are no family relationships between any of the above officers.
94
The Company has a Code of Conduct that includes the NYSE requirements for a “Code of Business Conduct and Ethics” and the SEC requirements for a “Code of Ethics for Senior Financial Officers.” The Code of Conduct is applicable to all directors, officers, and employees of the Company, including the principal executive officer, principal financial officer, and principal accounting officer. A copy of the Code of Conduct is available through the “Investors-Governance” section of the Company’s website at www.universalcorp.com. If the Company amends a provision of the Code of Conduct, or grants a waiver from any such provision to a director or executive officer, the Company will disclose such amendments and the details of such waivers on the Company’s website www.universalcorp.com to the extent required by the SEC or the NYSE.
Other than the matters set forth above, the information required by Item 401 of Regulation S-K is contained under the caption “Proposal One - Election of Directors” of the 2026 Proxy Statement and such information is incorporated by reference herein.
The information required by Item 405 of Regulation S-K is contained under the caption “Stock Ownership—Delinquent Section 16(a) Reports” of the 2026 Proxy Statement and such information is incorporated herein.
The information required by Item 406, Items 407(c)(3), (d)(4) and (d)(5), and Item 408(b) of Regulation S-K is contained under the captions “Corporate Governance and Committees—Committees of the Board—Nominating, Governance and Risk Committee” and “Corporate Governance and Committees—Committees of the Board—Audit Committee” of the 2026 Proxy Statement and such information is incorporated by reference herein.
The information required by Item 408(b) of Regulation S-K is contained under the caption “Corporate Governance and Committees—Insider Trading Policy” of the 2026 Proxy Statement and such information is incorporated by reference herein.
Item 11. Executive Compensation
Refer to the captions “Compensation Discussion and Analysis,” “Executive Compensation,” “Report of the Compensation and Human Resources Committee,” “Compensation and Human Resources Committee Interlocks and Inside Participation” and “Directors’ Compensation” in the 2026 Proxy Statement, which information is incorporated herein by reference.
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
Refer to the caption “Stock Ownership” and “Equity Compensation Information” in the 2026 Proxy Statement, which information is incorporated herein by reference.
Item 13. Certain Relationships and Related Transactions, and Director Independence
Refer to the caption “Certain Transactions” in the Company’s 2026 Proxy Statement, which information is incorporated herein by reference. The information required by Item 407(a) of Regulation S-K is contained under the caption “Corporate Governance and Committees—Director Independence” of the 2026 Proxy Statement and such information is incorporated by reference herein.
Item 14. Principal Accountant Fees and Services
Refer to the captions “Audit Information – Fees of Independent Registered Public Accounting Firm” and “Audit Information – Pre-Approval Policies and Procedures” in the 2026 Proxy Statement, which information is incorporated herein by reference.
95
PART IV
Item 15. Exhibits and Financial Statement Schedules
(a) The following are filed as part of this Annual Report:
1. Financial Statements .
Consolidated Statements of Income for the Fiscal Years Ended March 31, 2026, 2025, and 2024
Consolidated Statements of Comprehensive Income for the Fiscal Years Ended March 31, 2026, 2025, and 2024
Consolidated Balance Sheets at March 31, 2026 and 2025
Consolidated Statements of Cash Flows for the Fiscal Years Ended March 31, 2026, 2025, and 2024
Consolidated Statements of Changes in Shareholders’ Equity for the Fiscal Years Ended March 31, 2026, 2025, and 2024
Notes to Consolidated Financial Statements for the Fiscal Years Ended March 31, 2026, 2025, and 2024
Report of Ernst & Young LLP, Independent Registered Public Accounting Firm (PCAOB ID 42 )
Report of Ernst & Young LLP, Independent Registered Public Accounting Firm, on Internal Control Over Financial Reporting (PCAOB ID 42 )
2. Financial Statement Schedules .
Schedule II – Valuation and Qualifying Accounts
3. Exhibits . The exhibits are listed in the Exhibit Index immediately prior to the signature pages to this Annual Report.
(b) Exhibits
The response to this portion of Item 15 is submitted as a separate section to this Annual Report.
(c) Financial Statement Schedules
Schedule II – Valuation and Qualifying Accounts appears on the following page of this Annual Report. All other schedules are not required under the related instructions or are not applicable and therefore have been omitted.
Item 16. Form 10-K Summary
None.
96
Schedule II - Valuation and Qualifying Accounts
Universal Corporation
Fiscal Years Ended March 31, 2026, 2025, and 2024
Description Balance at
Beginning
of Year Net
Additions
(Reversals) Charged
to Expense Additions
Charged
to Other
Accounts Deductions (1)
Balance
at End
of Year
(in thousands of dollars)
Fiscal Year Ended March 31, 2024:
Allowance for doubtful accounts (deducted from accounts receivable) $ 1,612 $ 1,608 $ — $ ( 484 ) $ 2,736
Allowance for supplier accounts (deducted from advances to suppliers and other noncurrent assets) 24,387 14,090 — ( 18,834 ) 19,643
Allowance for recoverable taxes (deducted from other current assets and other noncurrent assets) 21,636 ( 276 ) — 15 21,375
Fiscal Year Ended March 31, 2025:
Allowance for doubtful accounts (deducted from accounts receivable) $ 2,736 $ 288 $ — $ ( 773 ) $ 2,251
Allowance for supplier accounts (deducted from advances to suppliers and other noncurrent assets) 19,643 1,938 — ( 3,908 ) 17,673
Allowance for recoverable taxes (deducted from other current assets and other noncurrent assets) 21,375 415 — ( 745 ) 21,045
Fiscal Year Ended March 31, 2026:
Allowance for doubtful accounts (deducted from accounts receivable) $ 2,251 $ 771 $ — $ ( 199 ) $ 2,823
Allowance for supplier accounts (deducted from advances to suppliers and other noncurrent assets) 17,673 6,258 — ( 8,187 ) 15,744
Allowance for recoverable taxes (deducted from other current assets and other noncurrent assets) 21,045 1,364 — 52 22,461
(1) Includes direct write-offs of assets and currency remeasurement.
97
EXHIBIT INDEX
3.1 Amended and Restated Articles of Incorporation, effective August 9, 2011 (incorporated herein by reference to the Registrant’s Current Report on Form 8-K Registration Statement dated August 9, 2011, File No. 001-00652).
3.2 Amended and Restated Bylaws, effective as of April 17, 2025 (incorporated herein by reference to the Registrant's Quarterly Report on Form 10-Q for the quarter ended December 31, 2024. File No. 001-00652).
4.1 Description of Registrant’s Securities Pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (incorporated herein by reference to the Registrant’s Annual Report on Form 10-K/A for the fiscal year ended March 31, 2024, File No. 001-00652).
4.2 Indenture between the Registrant and Chemical Bank, as trustee (incorporated herein by reference to the Registrant’s Current Report on Form 8-K dated February 25, 1991, File No. 001-00652).
4.3 Specimen Common Stock Certificate (incorporated herein by reference to the Registrant’s Amendment No. 1 to Registrant’s Form 8-A Registration Statement, dated May 7, 1999, File No. 001-00652).
10.1† Form of Universal Leaf Tobacco Company, Incorporated Executive Life Insurance Agreement (incorporated herein by reference to the Registrant’s Annual Report on Form 10-K for the fiscal year ended June 30, 1994, File No. 001-00652).
10.2† Universal Leaf Tobacco Company, Incorporated Deferred Income Plan (incorporated herein by reference to the Registrant’s Current Report on Form 8-K, dated February 8, 1991, File No. 001-00652).
10.3† Universal Leaf Tobacco Company, Incorporated Benefit Replacement Plan (incorporated herein by reference to the Registrant’s Current Report on Form 8-K, dated February 8, 1991, File No. 001-00652).
10.4† Universal Leaf Tobacco Company, Incorporated 1994 Benefit Replacement Plan (incorporated herein by reference to the Registrant’s Annual Report on Form 10-K for the fiscal year ended June 30, 1994, File No. 001-00652).
10.5† Universal Leaf Tobacco Company, Incorporated 1996 Benefit Restoration Plan (incorporated herein by reference to the Registrant’s Annual Report on Form 10-K for the fiscal year ended June 30, 1996, File No. 001-00652).
10.6† Universal Leaf Tobacco Company, Incorporated 1994 Deferred Income Plan, amended and restated as of July 1, 1998 (incorporated herein by reference to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 1998, File No. 001-00652).
10.7† Universal Corporation Outside Directors’ Deferred Income Plan, restated as of October 1, 1998 (incorporated herein by reference to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 1998, File No. 001-00652).
10.8† Revised Form of Universal Corporation Non-Employee Director Restricted Stock Agreement (incorporated herein by reference to the Registrant’s Current Report on Form 8-K, dated June 9, 2010, File No. 001-00652).
10.9† Universal Corporation Director’s Charitable Award Program (incorporated herein by reference to the Registrant’s Annual Report on Form 10-K for the fiscal year ended June 30, 1998, File No. 001-00652).
10.10† Universal Corporation 1997 Executive Stock Plan, as amended on August 7, 2003 (incorporated herein by reference to the Registrant’s Annual Report on Form 10-K for the fiscal year ended June 30, 2003, File No. 001-00652).
10.11† Universal Corporation 2002 Executive Stock Plan, as amended on August 7, 2003 (incorporated herein by reference to the Registrant’s Annual Report on Form 10-K for the fiscal year ended June 30, 2003, File No. 001-00652).
10.12† Form of Restricted Stock Units Award Agreement (incorporated herein by reference to the Registrant’s Current Report on Form 8-K, dated November 10, 2008, File No. 001-00652).
10.13† Universal Corporation 2007 Amended and Restated Stock Incentive Plan effective August 7, 2012 (incorporated herein by reference to Exhibit A to the Registrant’s definitive proxy statement filed June 28, 2012, File No. 001-00652).
98
10.14† Amended and Restated Universal Corporation Executive Officer Annual Incentive Plan (incorporated herein by reference to Exhibit A to the Registrant's definitive proxy statement filed July 24, 2019, File No. 001-00652).
10.15† Universal Corporation 2017 Stock Incentive Plan (incorporated herein by reference to Exhibit A to the Registrant's definitive proxy statement filed June 26, 2017, File No. 001-00652).
10.16† Universal Corporation 2023 Stock Incentive Plan (incorporated herein by reference to the Registrant's definitive proxy statement filed June 23, 2023, File No. 001-00652).
10.17† Form of Universal Corporation 2010 Restricted Stock Units Agreement with Schedule of Awards to named executive officers (incorporated herein by reference to the Registrant’s Annual Report on Form 10-K for the fiscal year ended March 31, 2010, File No. 001-00652).
10.18† Universal Leaf Tobacco Company, Incorporated Deferred Income Plan III, amended and restated as of December 31, 2008 (incorporated herein by reference to the Registrant's Annual Report on Form 10-K for the fiscal year ended March 31, 2010, File No. 001-00652).
10.19† Universal Corporation Outside Directors’ Deferred Income Plan III, amended and restated as of December 31, 2008, and amended as of February 1, 2010 (incorporated herein by reference to the Registrant's Annual Report on Form 10-K for the fiscal year ended March 31, 2010, File No. 001-00652).
10.20† Form of Universal Corporation 2011 Restricted Stock Units Award Agreement (incorporated herein by reference to the Registrant's Annual Report on Form 10-K for the fiscal year ended March 31, 2011, File No. 001-00652).
10.21† Form of Universal Corporation Performance Share Award Agreement (incorporated herein by reference to the Registrant's Annual Report on Form 10-K for the fiscal year ended March 31, 2011, File No. 001-00652).
10.22† Executive Change in Control Severance Policy (incorporated herein by reference to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2020, File No. 001-00652).
10.23† Form of Universal Corporation 2021 Performance Stock Units Award Agreement (incorporated herein by reference to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2021, File No. 001-00652).
10.24† Form of Universal Corporation 2021 Restricted Stock Units Award Agreement (incorporated herein by reference to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2021, File No. 001-00652).
10.25 Credit Agreement dated December 9, 2025 among the Company, JPMorgan Chase Bank, N.A., as Administrative Agent, Truist Bank and AgFirst Farm Credit Bank, as Co-Syndication Agents and First Horizon, KeyBank National Association, Citibank, N.A., Bank of America, N.A., UBS Switzerland AG, Atlantic Union Bank, and Capital One N.A., as Co-Documentation Agents (incorporated herein by reference to the Registrant’s Current Report on Form 8-K dated December 9, 2025, File No. 001-00652).
10.26† Form of Universal Corporation Non-employee Director Restricted Stock Units Award Agreement (incorporated herein by reference to the Registrant's Annual Report on Form 10-K for the fiscal year ended March 31, 2025, File No. 001-000652).
10.27† Form of Universal Corporation Performance Stock Units Award Agreement (incorporated herein by reference to the Registrant's Annual Report on Form 10-K for the fiscal year ended March 31, 2025, File No. 001-000652).
10.28† Form of Restricted Stock Units Award Agreement (incorporated herein by reference to the Registrant's Annual Report on Form 10-K for the fiscal year ended March 31, 2025, File No. 001-000652).
10.29† Restricted Stock Units Award Agreement, dated May 30, 2025, between Universal Corporation and Airton L. Hentschke (incorporated herein by reference to the Registrant's Annual Report on Form 10-K for the fiscal year ended March 31, 2025, File No. 001-000652).
10.30† Amended and Restated Universal Corporation Executive Officer Annual Incentive Plan (incorporated herein by reference to the Registrant's Quarterly Report for the quarter ended June 30, 2025, File No. 001-000652).
10.31† Restricted Stock Units Award Agreement, dated July 11, 2025, between Universal Corporation and Johan C. Kroner (incorporated herein by reference to the Registrant's Current Report on Form 8-K dated July 11, 2025, File No. 001-000652).
99
19.1 Universal Corporation Insider Trading Policy and Procedures (incorporated herein by reference to the Registrant’s Annual Report on Form 10-K/A for the year ended March 31, 2024, File No. 001-00652).
21 Subsidiaries of the Registrant.*
23 Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm.*
31.1 Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
31.2 Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
32.1 Statement of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350.*
32.2 Statement of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350.*
97.1 Universal Corporation Dodd-Frank Clawback Policy (incorporated herein by reference to the Registrant’s Annual Report on Form 10-K/A for the year ended March 31, 2024, File No. 001-00652).
101 Interactive Data Files (submitted electronically herewith)*
101.INS XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. 101.SCH XBRL Taxonomy Extension Schema Document 101.CAL XBRL Taxonomy Extension Calculation Linkbase Document 101.DEF XBRL Taxonomy Extension Definition Linkbase Document 101.LAB XBRL Taxonomy Extension Label Linkbase Document 101.PRE XBRL Taxonomy Extension Presentation Linkbase Document In accordance with Rule 406T of Regulation S-T, the XBRL related information in Exhibit 101 to this Annual Report on Form 10-K shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section and shall not be part of any registration or other document filed under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
* Filed herewith.
† Management contract or compensatory plan or arrangement.
100
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
UNIVERSAL CORPORATION
June 1, 2026
By: /s/ PRESTON D. WIGNER
Preston D. Wigner
Chairman, President, and Chief Executive Officer
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
Signature Title Date
/s/ PRESTON D. WIGNER Chairman, President, Chief Executive Officer, and Director June 1, 2026
Preston D. Wigner (Principal Executive Officer)
/s/ STEVEN S. DIEL Senior Vice President and Chief Financial Officer June 1, 2026
Steven S. Diel (Principal Financial Officer)
/s/ SCOTT J. BLEICHER Vice President and Controller June 1, 2026
Scott J. Bleicher (Principal Accounting Officer)
/s/ DIANA F. CANTOR Director June 1, 2026
Diana F. Cantor
/s/ LENNART R. FREEMAN Director June 1, 2026
Lennart R. Freeman
/s/ THOMAS H. JOHNSON Director June 1, 2026
Thomas H. Johnson
/s/ FOTINI E. MANOLIOS Director June 1, 2026
Fotini E. Manolios
/s/ ARTHUR J. SCHICK, JR. Director June 1, 2026
Arthur J. Schick, Jr.
/s/ ROBERT C. SLEDD Director June 1, 2026
Robert C. Sledd
/s/ GREGORY A. TROJAN Director June 1, 2026
Gregory A. Trojan
/s/ THOMAS H. TULLIDGE, JR. Director June 1, 2026
Thomas H. Tullidge, Jr.
/s/ JACQUELINE T. WILLIAMS Director June 1, 2026
Jacqueline T. Williams
101